Weining K. Zhen
Expertise in
20
conditions

Dr. Weining K. Zhen

Radiation Oncology
505 S 45th St., 
Omaha, NE 
Accepting New Patients
Offers Telehealth
Expertise in
20
conditions
505 S 45th St., 
Omaha, NE 

Overview

Weining Zhen is a Radiation Oncologist practicing medicine in Omaha, Nebraska.

Dr. Zhen is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Laryngeal Cancer, and Gastrostomy.

He is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 8 clinical trials. Dr. Zhen is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in NE

Hospital Affiliations

Bellevue Medical Center
The Nebraska Medical Center

Languages Spoken

English
American Sign Language
Japanese
Mandarin

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 8 Less Insurance Carriers -

Locations

Fred & Pamela Buffett Cancer Center - Nebraska Medical Center
505 S 45th St., Omaha, NE 68105
Other Locations
Radiation Oncology at Village Pointe Health Center
111 N 175th St., Omaha, NE 68118

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Enrollment Status: Suspended
Publish Date: September 04, 2026
Intervention Type: Procedure, Radiation, Drug
Study Drug: Atezolizumab
Study Phase: Phase 2/Phase 3
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: June 11, 2026
Intervention Type: Other, Drug, Procedure, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 3
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: May 22, 2026
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Phase 1 / Phase 2 Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer
A Phase 1 / Phase 2 Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer
Enrollment Status: Completed
Publish Date: March 15, 2023
Intervention Type: Drug, Radiation
Study Drugs: BMX-001, Cisplatin
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

43 Total Publications

Role of Intermediate dose escalation of radiotherapy in the survival of unresectable stage III non-small cell lung cancer patients in the era of immunotherapy.
Role of Intermediate dose escalation of radiotherapy in the survival of unresectable stage III non-small cell lung cancer patients in the era of immunotherapy.
Journal: Frontiers in oncology
Published: June 23, 2025
Similar Doctors
Expertise in
18
conditions
Dr. Chi S. Lin
Radiation Oncology
Expertise in
18
conditions
Dr. Chi S. Lin
Radiation Oncology
Referral may be required

Fred & Pamela Buffett Cancer Center - Nebraska Medical Center

505 S 45th St., 
Omaha, NE 
 (0.1 miles away)
402-559-5600
Languages Spoken:
English, American Sign Language, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Chi Lin is a Radiation Oncologist practicing medicine in Omaha, Nebraska. Dr. Lin is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Lung Cancer, Anal Cancer, Small Cell Lung Cancer (SCLC), and Pancreaticoduodenectomy. Dr. Lin is currently accepting new patients.

Expertise in
28
conditions
Dr. T William-Huang
Radiation Oncology
Expertise in
28
conditions
Dr. T William-Huang
Radiation Oncology
Referral may be required

Methodist Estabrook Cancer Center Radiation Oncology

8303 Dodge St # 6, 
Omaha, NE 
 (3.7 miles away)
402-354-4104
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients

T William-Huang is a Radiation Oncologist practicing medicine in Omaha, Nebraska. Dr. William-Huang is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Pleuropulmonary Blastoma, Lung Cancer, and Primitive Neuroectodermal Tumor (PNET). Dr. William-Huang is currently accepting new patients.

Expertise in
24
conditions
Dr. Andrew O. Wahl
Radiation Oncology
Expertise in
24
conditions
Dr. Andrew O. Wahl
Radiation Oncology
Referral may be required

Fred & Pamela Buffett Cancer Center - Nebraska Medical Center

505 S 45th St., 
Omaha, NE 
 (0.1 miles away)
402-559-5600
Languages Spoken:
English, American Sign Language
See accepted insurances
Accepting New Patients

Andrew Wahl is a Radiation Oncologist practicing medicine in Omaha, Nebraska. Dr. Wahl is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Breast Cancer, Angiosarcoma, and Adult Soft Tissue Sarcoma. Dr. Wahl is currently accepting new patients.

Frequently Asked Questions about Dr. Weining K. Zhen

How do I make an appointment with Dr. Weining K. Zhen?

You can book an appointment with Dr. Weining K. Zhen by calling their office at 402-559-5600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Weining K. Zhen a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Weining K. Zhen is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Weining K. Zhen specialize in?

While Dr. Weining K. Zhen is a Radiation Oncology, they have specific expertise in Lung Cancer, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Weining K. Zhen participate in research or clinical trials?

Yes. Dr. Weining K. Zhen has published 43 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Weining K. Zhen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Weining K. Zhen accept my insurance?

Dr. Weining K. Zhen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 402-559-5600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zhen's expertise for a condition
ConditionClose
    View All 11 Distinguished Conditions
    View All 9 Advanced Conditions
    View All 61 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile